| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000157.txt","as_of":"2026-04-17T02:13:18.114675+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000157.txt","company":"SOPHiA GENETICS SA","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000157.txt","article_chars":2162,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_f6b1fd494dc06466","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000157.txt","content_type":"text/plain","enriched_at":"2026-04-17T08:15:08.330147+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000157.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000157.txt","source_event_id":"evt_23274fdc4a16","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"d7c17f960ebbf64a","kind":"sec_filing","published_at":"20260416","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-16","2026-04-14","2026-04-02","2026-04-03"],"entities":[{"asset_class":"equity","name":"SOPHiA GENETICS SA","relevance":"high","symbol":"SOPH","type":"issuer"},{"asset_class":"equity","name":"Ross Muken","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"Elimara Brunetto","relevance":"low","symbol":"","type":"attorney_in_fact"}],"event_type":"listing","information_gaps":["The text provided does not include the full Form 4 table fields (e.g., exact transaction-by-transaction breakdown beyond the stated price range and weighted average).","The signal does not include any prior-known state to explicitly compare what changed versus earlier filings (no delta baseline provided).","The filing type is identified as Form 4, but the specific number of shares remaining after the transaction is not present in the provided excerpt."],"key_facts":["SEC filing: Form 4 for SOPHiA GENETICS SA (issuer CI K 0001840706).","Filing was filed as of date 2026-04-16; conformed period of report is 2026-04-14.","Reporting owner: Ross Muken (company CI K 0002005463 shown in the text).","The filing states the sales represent shares sold in the open market to satisfy tax withholding obligations arising from vesting of restricted stock units on April 2 and 3, 2026.","The sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan and are described as not discretionary trades.","The price in Column 4 is a weighted average price.","Shares were sold in multiple transactions at prices ranging from $4.75 to $5.16 (inclusive).","The filing includes an undertaking to provide full information on the number of shares sold at each separate price within the stated range upon written request."],"numeric_claims":[{"label":"shares sold (reported quantity)","value":"2800"},{"label":"weighted average price (Column 4)","value":"4.9597"},{"label":"price range (min)","value":"4.75"},{"label":"price range (max)","value":"5.16"},{"label":"RSU vesting dates referenced","value":"2026-04-02 and 2026-04-03"},{"label":"sale transaction date referenced (conformed period of report)","value":"2026-04-14"}],"primary_claim":"Form 4 filed 2026-04-16 by SOPHiA GENETICS SA discloses that reporting owner Ross Muken sold ordinary shares on 2026-04-14 to satisfy tax withholding obligations from RSU vesting, under a Rule 10b5-1(c) trading plan.","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"SOPHiA GENETICS SA filed a Form 4 on 2026-04-16 reporting that insider Ross Muken sold ordinary shares on 2026-04-14 to satisfy tax withholding related to RSU vesting. The filing states the sales were executed under a pre-established Rule 10b5-1(c) plan and occurred at weighted-average and ranged prices.","topics":["SEC Form 4","insider trading","Rule 10b5-1(c) plan","RSU vesting","tax withholding","ordinary shares"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 SOPHiA GENETICS SA \u00b7 Filed 20260416","ticker":"SOPH","tickers":["SOPH"],"title":"SOPH filed 4","url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000157.txt"}... |